课题基金 / 基金详情

项目摘要

项目成果

John H Adams的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Plasmodium vivax resistant to chloroquine (CQ) is widely reported, seriously hampering the case management and malaria control/elimination effort. The molecular determinant and mechanism of resistance is unclear. As homologs of P. falciparum chloroquine resistance (CQR) determinant and other key molecules have been found not implicated in P. vivax CQR, it is clear that P. vivax has developed CQR using a mechanism different to P. falciparum. Therefore, we propose to use a whole genome recombineering type of approach, whereby the entire cDNA of a CQR P. vivax genome is cloned into piggyBac vector and transfected into a chloroquine sensitive (CQS) cultured line of P. falciparum. The transfected P. falciparum parasites will be cultured under CQ pressure and cloned by limiting dilution. cDNA-containing plasmids will be rescued from clones with growing parasites to identify candidate gene(s) that plays significant roles in P. vivax CQR. The outcome will enable large-scale monitor and surveillance of the spread of CQR P. vivax, provide predictive value for treatment outcome and provide information for policy changes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
  • 批准号:
    10307530
  • 项目类别:
  • 资助金额:
    $97.6万
  • 财政年份:
    2020
  • 负责人:
    John H Adams
  • 依托单位:
Evaluation of ivermectin as an antimalarial therapy against P. falciparum liver stage
  • 批准号:
    10001705
  • 项目类别:
  • 资助金额:
    $20.4万
  • 财政年份:
    2020
  • 负责人:
    John H Adams
  • 依托单位:
Plasmodium ovale hypnozoite development and relapse: a coordinated in vivo in vitro study
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
  • 批准号:
    10526422
  • 项目类别:
  • 资助金额:
    $97.55万
  • 财政年份:
    2020
  • 负责人:
    John H Adams
  • 依托单位:
海外基金